Report cover image

Global Tigecycline Market by Size, by Type, by Application, by Region, History and Forecast 2020-2031

Publisher APO Research, Inc.
Published Feb 08, 2025
Length 190 Pages
SKU # APRC19872228

Description

Summary

Tigecycline is the first drug in the glycyltetracycline class (a modified form of minocycline). It is a new broad-spectrum intravenous antibiotic developed by pfizer (wyeth). It is effective against drug-resistant mrsa.

According to APO Research, The global Tigecycline market is projected to grow from US$ million in 2025 to US$ million by 2031, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Tigecycline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Tigecycline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The China market for Tigecycline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for Tigecycline is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of Tigecycline include Pfizer (Wyeth), Sino Biopharmaceutical, Zhejiang Hisun Pharma, Jiangsu Hansoh Pharmaceutical, Abbott, Natco Pharma, Lyka Labs Limited, Fresenius Kabi and Sandoz, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Tigecycline, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2020-2024, estimates for 2025, and projections of CAGR through 2031.

This report researches the key producers of Tigecycline, also provides the sales of main regions and countries. Of the upcoming market potential for Tigecycline, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Tigecycline sales, revenue, market share and industry ranking of main manufacturers, data from 2020 to 2025. Identification of the major stakeholders in the global Tigecycline market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2020 to 2031. Evaluation and forecast the market size for Tigecycline sales, projected growth trends, production technology, application and end-user industry.


Tigecycline Segment by Company

Pfizer (Wyeth)
Sino Biopharmaceutical
Zhejiang Hisun Pharma
Jiangsu Hansoh Pharmaceutical
Abbott
Natco Pharma
Lyka Labs Limited
Fresenius Kabi
Sandoz
APOTEX
Accord Healthcare
Amneal Pharmaceuticals

Tigecycline Segment by Type

Original Drug
Generic Drug

Tigecycline Segment by Application

Hospital Pharmacies
Retail Pharmacies

Tigecycline Segment by Region

North America

United States

Canada

Mexico
Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland
Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia
South America

Brazil

Argentina

Chile
Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Tigecycline market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Tigecycline and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Tigecycline.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Tigecycline market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2020-2031).
Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Tigecycline manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Tigecycline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Revenue of Tigecycline in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights of the report

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.

Table of Contents

190 Pages
1 Market Overview
1.1 Product Definition
1.2 Global Tigecycline Market Size, 2020 VS 2024 VS 2031
1.3 Global Tigecycline Market Size Estimates and Forecasts (2020-2031)
1.4 Global Tigecycline Sales Estimates and Forecasts (2020-2031)
1.5 Global Tigecycline Market Average Price (2020-2031)
1.6 Assumptions and Limitations
1.7 Study Goals and Objectives
2 Global Tigecycline Market Dynamics
2.1 Tigecycline Industry Trends
2.2 Tigecycline Industry Drivers
2.3 Tigecycline Industry Opportunities and Challenges
2.4 Tigecycline Industry Restraints
3 Tigecycline Market by Manufacturers
3.1 Global Tigecycline Revenue by Manufacturers (2020-2025)
3.2 Global Tigecycline Sales by Manufacturers (2020-2025)
3.3 Global Tigecycline Average Sales Price by Manufacturers (2020-2025)
3.4 Global Tigecycline Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global Tigecycline Key Manufacturers Manufacturing Sites & Headquarters
3.6 Global Tigecycline Manufacturers, Product Type & Application
3.7 Global Tigecycline Manufacturers Establishment Date
3.8 Market Competitive Analysis
3.8.1 Global Tigecycline Market CR5 and HHI
3.8.2 Global Top 5 and 10 Tigecycline Players Market Share by Revenue in 2024
3.8.3 2024 Tigecycline Tier 1, Tier 2, and Tier 3
4 Tigecycline Market by Type
4.1 Tigecycline Type Introduction
4.1.1 Original Drug
4.1.2 Generic Drug
4.2 Global Tigecycline Sales by Type
4.2.1 Global Tigecycline Sales by Type (2020 VS 2024 VS 2031)
4.2.2 Global Tigecycline Sales by Type (2020-2031)
4.2.3 Global Tigecycline Sales Market Share by Type (2020-2031)
4.3 Global Tigecycline Revenue by Type
4.3.1 Global Tigecycline Revenue by Type (2020 VS 2024 VS 2031)
4.3.2 Global Tigecycline Revenue by Type (2020-2031)
4.3.3 Global Tigecycline Revenue Market Share by Type (2020-2031)
5 Tigecycline Market by Application
5.1 Tigecycline Application Introduction
5.1.1 Hospital Pharmacies
5.1.2 Retail Pharmacies
5.2 Global Tigecycline Sales by Application
5.2.1 Global Tigecycline Sales by Application (2020 VS 2024 VS 2031)
5.2.2 Global Tigecycline Sales by Application (2020-2031)
5.2.3 Global Tigecycline Sales Market Share by Application (2020-2031)
5.3 Global Tigecycline Revenue by Application
5.3.1 Global Tigecycline Revenue by Application (2020 VS 2024 VS 2031)
5.3.2 Global Tigecycline Revenue by Application (2020-2031)
5.3.3 Global Tigecycline Revenue Market Share by Application (2020-2031)
6 Global Tigecycline Sales by Region
6.1 Global Tigecycline Sales by Region: 2020 VS 2024 VS 2031
6.2 Global Tigecycline Sales by Region (2020-2031)
6.2.1 Global Tigecycline Sales by Region (2020-2025)
6.2.2 Global Tigecycline Sales Forecasted by Region (2025-2030)
6.3 North America
6.3.1 North America Tigecycline Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America Tigecycline Sales by Country (2020-2031)
6.3.3 U.S.
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe Tigecycline Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe Tigecycline Sales by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Netherlands
6.5 Asia Pacific
6.5.1 Asia Pacific Tigecycline Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific Tigecycline Sales by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 Southeast Asia
6.5.7 India
6.5.8 Australia
6.6 South America, Middle East and Africa
6.6.1 South America, Middle East and Africa Tigecycline Sales Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East and Africa Tigecycline Sales by Country (2020-2031)
6.6.3 Brazil
6.6.4 South Africa
6.6.5 Saudi Arabia
6.6.6 Turkey
6.6.6 Argentina
6.6.6 UAE
6.6.6 Egypt
6.6.6 Chile
7 Global Tigecycline Revenue by Region
7.1 Global Tigecycline Revenue by Region
7.1.1 Global Tigecycline Revenue by Region: 2020 VS 2024 VS 2031
7.1.2 Global Tigecycline Revenue by Region (2020-2025)
7.1.3 Global Tigecycline Revenue by Region (2026-2031)
7.1.4 Global Tigecycline Revenue Market Share by Region (2020-2031)
7.2 North America
7.2.1 North America Tigecycline Revenue (2020-2031)
7.2.2 North America Tigecycline Revenue Share by Country: 2020 VS 2024 VS 2031
7.3 Europe
7.3.1 Europe Tigecycline Revenue (2020-2031)
7.3.2 Europe Tigecycline Revenue Share by Country: 2020 VS 2024 VS 2031
7.4 Asia-Pacific
7.4.1 Asia-Pacific Tigecycline Revenue (2020-2031)
7.4.2 Asia-Pacific Tigecycline Revenue Share by Country: 2020 VS 2024 VS 2031
7.5 South America, Middle East and Africa
7.5.1 South America, Middle East and Africa Tigecycline Revenue (2020-2031)
7.5.2 South America, Middle East and Africa Tigecycline Revenue Share by Country: 2020 VS 2024 VS 2031
8 Company Profiles
8.1 Pfizer (Wyeth)
8.1.1 Pfizer (Wyeth) Comapny Information
8.1.2 Pfizer (Wyeth) Business Overview
8.1.3 Pfizer (Wyeth) Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.1.4 Pfizer (Wyeth) Tigecycline Product Portfolio
8.1.5 Pfizer (Wyeth) Recent Developments
8.2 Sino Biopharmaceutical
8.2.1 Sino Biopharmaceutical Comapny Information
8.2.2 Sino Biopharmaceutical Business Overview
8.2.3 Sino Biopharmaceutical Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.2.4 Sino Biopharmaceutical Tigecycline Product Portfolio
8.2.5 Sino Biopharmaceutical Recent Developments
8.3 Zhejiang Hisun Pharma
8.3.1 Zhejiang Hisun Pharma Comapny Information
8.3.2 Zhejiang Hisun Pharma Business Overview
8.3.3 Zhejiang Hisun Pharma Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.3.4 Zhejiang Hisun Pharma Tigecycline Product Portfolio
8.3.5 Zhejiang Hisun Pharma Recent Developments
8.4 Jiangsu Hansoh Pharmaceutical
8.4.1 Jiangsu Hansoh Pharmaceutical Comapny Information
8.4.2 Jiangsu Hansoh Pharmaceutical Business Overview
8.4.3 Jiangsu Hansoh Pharmaceutical Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.4.4 Jiangsu Hansoh Pharmaceutical Tigecycline Product Portfolio
8.4.5 Jiangsu Hansoh Pharmaceutical Recent Developments
8.5 Abbott
8.5.1 Abbott Comapny Information
8.5.2 Abbott Business Overview
8.5.3 Abbott Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.5.4 Abbott Tigecycline Product Portfolio
8.5.5 Abbott Recent Developments
8.6 Natco Pharma
8.6.1 Natco Pharma Comapny Information
8.6.2 Natco Pharma Business Overview
8.6.3 Natco Pharma Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.6.4 Natco Pharma Tigecycline Product Portfolio
8.6.5 Natco Pharma Recent Developments
8.7 Lyka Labs Limited
8.7.1 Lyka Labs Limited Comapny Information
8.7.2 Lyka Labs Limited Business Overview
8.7.3 Lyka Labs Limited Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.7.4 Lyka Labs Limited Tigecycline Product Portfolio
8.7.5 Lyka Labs Limited Recent Developments
8.8 Fresenius Kabi
8.8.1 Fresenius Kabi Comapny Information
8.8.2 Fresenius Kabi Business Overview
8.8.3 Fresenius Kabi Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.8.4 Fresenius Kabi Tigecycline Product Portfolio
8.8.5 Fresenius Kabi Recent Developments
8.9 Sandoz
8.9.1 Sandoz Comapny Information
8.9.2 Sandoz Business Overview
8.9.3 Sandoz Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.9.4 Sandoz Tigecycline Product Portfolio
8.9.5 Sandoz Recent Developments
8.10 APOTEX
8.10.1 APOTEX Comapny Information
8.10.2 APOTEX Business Overview
8.10.3 APOTEX Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.10.4 APOTEX Tigecycline Product Portfolio
8.10.5 APOTEX Recent Developments
8.11 Accord Healthcare
8.11.1 Accord Healthcare Comapny Information
8.11.2 Accord Healthcare Business Overview
8.11.3 Accord Healthcare Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.11.4 Accord Healthcare Tigecycline Product Portfolio
8.11.5 Accord Healthcare Recent Developments
8.12 Amneal Pharmaceuticals
8.12.1 Amneal Pharmaceuticals Comapny Information
8.12.2 Amneal Pharmaceuticals Business Overview
8.12.3 Amneal Pharmaceuticals Tigecycline Sales, Price, Revenue and Gross Margin (2020-2025)
8.12.4 Amneal Pharmaceuticals Tigecycline Product Portfolio
8.12.5 Amneal Pharmaceuticals Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Tigecycline Value Chain Analysis
9.1.1 Tigecycline Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Tigecycline Production Mode & Process
9.2 Tigecycline Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Tigecycline Distributors
9.2.3 Tigecycline Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources
11.6 Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.